Filter by
News (12)
RSS![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-07/AdobeStock_378144124.jpeg?h=51a72048&itok=1H_AJMiG)
ACT EU has published two new webpages with information of interest to the network and clinical trial stakeholders.
![Female medical research scientist working in a modern laboratory and typing information obtained from new experimental drug trial](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-09/ACT-EU_news_clinical%20trials.png?itok=8GzIlCgY)
Revised rules for Clinical Trials Information System (CTIS) become applicable.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-06/AdobeStock_655082213.jpeg?h=3d38b876&itok=cVQJbUAU)
Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-04/AdobeStock_595278401.jpeg?h=fa5f4214&itok=4QaqC787)
The revised transparency rules for the Clinical Trials Information System (CTIS) will become applicable on 18 June 2024, with the launch of a new version of the CTIS public portal.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-03/AdobeStock_198189095.jpeg?h=fa1c963e&itok=WhXmjh5w)
The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU).
![Medical professional looking at desktop screen](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-01/AdobeStock_603009000%20%281%29.jpeg?itok=6Gvt3Ajm)
All ongoing clinical trials in the EU must be transitioned to the Clinical Trials Information System (CTIS) by 31 January 2025.
The ACT EU workplan for 2023-2026 is now available, with updated priorities to improve the clinical trials environment in Europe.
![A Diverse team putting their hands together, representing teamwork.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-10/2023-10_ACT%20EU%20advisory%20group%20multistakeholder%20platform-2-EWPP%20web%20image.png?itok=Hm_vxp4y)
Interested stakeholders may express their interest in becoming a member of the Multi-stakeholder platform Advisory Group by 24 November 2023.
![Female medical research scientist working in a modern laboratory and typing information obtained from new experimental drug trial](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-09/ACT-EU_news_clinical%20trials.png?itok=8GzIlCgY)
EMA revised rules to give faster access to information in the EU Clinical Trials Information System (CTIS).
![Document icon in a blue background.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-12/MicrosoftTeams-image%20%2816%29.png?itok=lVHWoA38)
The summary report has been published as an outcome of the first ACT EU MSP workshop held in June 2023.